Britannia Life Sciences Inc
CNSX:BLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Britannia Life Sciences Inc
Total Current Liabilities
Britannia Life Sciences Inc
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Britannia Life Sciences Inc
CNSX:BLAB
|
Total Current Liabilities
CA$3.7m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
High Tide Inc
XTSX:HITI
|
Total Current Liabilities
CA$93.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Canopy Growth Corp
TSX:WEED
|
Total Current Liabilities
CA$98.3m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
35%
|
|
|
Aurora Cannabis Inc
TSX:ACB
|
Total Current Liabilities
CA$145.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
34%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Total Current Liabilities
CA$92.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Total Current Liabilities
$48.2m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
40%
|
|
Britannia Life Sciences Inc
Glance View
Britannia Life Sciences, Inc. is a global product development platform. The company is headquartered in Toronto, Ontario. The company went IPO on 2017-12-01. The firm's platform offers an integrated suite of services to assist companies along their product development journey. The firm provides product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally. The company is also engaged in the development and regulatory approval of topical and edible cannabis products, including preparation and support for food authorizations. The company serves consumer packaged goods (CPG), cosmetics, household goods and nutraceutical industries, blue-chip, food and beverage, nutraceutical sectors, toiletries, small and medium enterprise (SME) clients.
See Also
What is Britannia Life Sciences Inc's Total Current Liabilities?
Total Current Liabilities
3.7m
CAD
Based on the financial report for Mar 31, 2025, Britannia Life Sciences Inc's Total Current Liabilities amounts to 3.7m CAD.
What is Britannia Life Sciences Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 3Y
-24%
Over the last year, the Total Current Liabilities growth was -65%. The average annual Total Current Liabilities growth rates for Britannia Life Sciences Inc have been -24% over the past three years .
